2,3-dinor-thromboxane b2 and Ischemia

2,3-dinor-thromboxane b2 has been researched along with Ischemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FitzGerald, GA; Friesinger, GC; Maas, RL; Oates, JA; Roberts, LJ; Robertson, D; Robertson, RM1
Bachi, A; Chiabrando, C; Corada, M; Fanelli, R1

Trials

1 trial(s) available for 2,3-dinor-thromboxane b2 and Ischemia

ArticleYear
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    The New England journal of medicine, 1981, Apr-23, Volume: 304, Issue:17

    Topics: Adult; Angina Pectoris; Angina Pectoris, Variant; Arteries; Aspirin; Clinical Trials as Topic; Coronary Circulation; Coronary Vessels; Double-Blind Method; Female; Humans; Indomethacin; Ischemia; Male; Middle Aged; Recurrence; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors; Veins

1981

Other Studies

1 other study(ies) available for 2,3-dinor-thromboxane b2 and Ischemia

ArticleYear
Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat.
    Prostaglandins, 1994, Volume: 47, Issue:6

    Topics: Animals; Ischemia; Liver; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Reperfusion; Thromboxane B2; Thromboxanes

1994